115 related articles for article (PubMed ID: 16121911)
1. [Endometrial cancer].
Kuzuya K; Nakanishi T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1110-5. PubMed ID: 16121911
[TBL] [Abstract][Full Text] [Related]
2. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
3. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
4. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
[TBL] [Abstract][Full Text] [Related]
5. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
6. The evolving role of adjuvant therapy in endometrial cancer.
Gadducci A; Greco C
Crit Rev Oncol Hematol; 2011 May; 78(2):79-91. PubMed ID: 20418109
[TBL] [Abstract][Full Text] [Related]
7. [Endometrial cancer -- suggestions for the update of the guidelines].
Emons G
Zentralbl Gynakol; 2006 Feb; 128(1):18-22. PubMed ID: 16450282
[TBL] [Abstract][Full Text] [Related]
8. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
[TBL] [Abstract][Full Text] [Related]
9. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer.
Zuurendonk LD; Smit RA; Mol BW; Feijen HW; de Graaff J; Sykora D; de Winter KA; vd Wurff A; Snijders MP; Kruitwagen RF
Eur J Surg Oncol; 2006 May; 32(4):450-4. PubMed ID: 16546343
[TBL] [Abstract][Full Text] [Related]
10. Role of complete para-aortic lymphadenectomy in endometrial cancer.
Fujimoto T; Fukuda J; Tanaka T
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):10-4. PubMed ID: 19124998
[TBL] [Abstract][Full Text] [Related]
11. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
Lin LL; Mutch DG; Rader JS; Powell MA; Grigsby PW
Gynecol Oncol; 2007 Jul; 106(1):215-20. PubMed ID: 17482665
[TBL] [Abstract][Full Text] [Related]
12. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
13. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.
Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T
Gynecol Oncol; 2006 Oct; 103(1):155-9. PubMed ID: 16545437
[TBL] [Abstract][Full Text] [Related]
14. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
[TBL] [Abstract][Full Text] [Related]
16. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
[TBL] [Abstract][Full Text] [Related]
17. Can we omit para-aorta lymph node dissection in endometrial cancer?
Tanaka H; Sato H; Miura H; Sato N; Fujimoto T; Konishi Y; Takahashi O; Tanaka T
Jpn J Clin Oncol; 2006 Sep; 36(9):578-81. PubMed ID: 16870694
[TBL] [Abstract][Full Text] [Related]
18. Surgery for endometrial cancer: what type and by whom?
Kitchener HC
Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):407-15. PubMed ID: 11476562
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.
Zusterzeel PL; Bekkers RL; Hendriks JC; Neesham DN; Rome RM; Quinn MA
Acta Obstet Gynecol Scand; 2008; 87(2):240-6. PubMed ID: 18231895
[TBL] [Abstract][Full Text] [Related]
20. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
